McDermott advised DiogenX in its fundraising. DiogenX, a biotechnology company specializing in the regeneration of beta cells that produce insulin for the treatment of diabetes, has...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here